Literature DB >> 24816819

Small juxtacortical hemorrhages in cerebral venous thrombosis.

Jonathan M Coutinho1, René van den Berg, Susanna M Zuurbier, Ed VanBavel, Dirk Troost, Charles B Majoie, Jan Stam.   

Abstract

OBJECTIVE: Intracerebral hemorrhages (ICHs) are common in patients with cerebral venous thrombosis (CVT). We examined whether small juxtacortical hemorrhages (JCHs) are characteristic for CVT and studied their radiological and pathological properties.
METHODS: We identified all patients with CVT and an ICH at baseline admitted between 2000 and 2011 (prospectively from July 2006). JCH was defined as a hemorrhage (diameter < 20mm) located in the white matter just below the cortex. To determine the specificity of JCHs for CVT, we examined the frequency of JCHs in a control group of patients of similar age with an ICH not related to CVT.
RESULTS: Of 114 patients with CVT, 53 had an ICH. JCHs were present in 14 of the 53 (26%). The remaining 39 had other kinds of hemorrhages. Papilledema was more common among patients with a JCH compared to patients with other types of ICHs (44% vs 9%, p = 0.01). All patients with a JCH except 1 had thrombosis of the superior sagittal sinus, compared to 49% of patients with CVT and other kinds of hemorrhages (p = 0.004). Reanalysis of all imaging data and histopathologic analysis in 1 patient showed that JCHs are located near the U-fibers and that they follow the curvature of the cortex. Among 196 control patients (spontaneous ICH, not caused by CVT), only 3 patients had a JCH. One of these 3 appeared on re-examination of all imaging results to have had CVT.
INTERPRETATION: Small nontraumatic JCHs are a characteristic feature of CVT and are rarely encountered in other conditions.
© 2014 American Neurological Association.

Entities:  

Mesh:

Year:  2014        PMID: 24816819     DOI: 10.1002/ana.24180

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Juxtacortical haemorrhage in cerebral venous sinus thrombosis: 'The Cashew Nut Sign'.

Authors:  Walid Moudrous; Cees Tijssen
Journal:  BMJ Case Rep       Date:  2015-08-21

Review 2.  Cerebral venous thrombosis.

Authors:  Suzanne M Silvis; Diana Aguiar de Sousa; José M Ferro; Jonathan M Coutinho
Journal:  Nat Rev Neurol       Date:  2017-08-18       Impact factor: 42.937

Review 3.  Diagnosis and management of cerebral venous thrombosis.

Authors:  Roya Behrouzi; Martin Punter
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

Review 4.  [Acute focal neurological deficits in the emergency room].

Authors:  C Dohmen; J Bösel
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

5.  Advances in the treatment of cerebral venous thrombosis.

Authors:  J M Coutinho; S Middeldorp; J Stam
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

6.  Hydrocephalus in cerebral venous thrombosis.

Authors:  Susanna M Zuurbier; René van den Berg; Dirk Troost; Charles B Majoie; Jan Stam; Jonathan M Coutinho
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

7.  Superior Sagittal Venous Sinus Thrombosis in a Patient with Illicit Testosterone Use.

Authors:  Ariba Hashmi; Paul Kim; Syed W Ahmad; Jason Faucheux; Naz Gandikal
Journal:  Cureus       Date:  2019-08-26

8.  Characteristics of Cerebral Sinus Venous Thrombosis Patients Presenting with Intracerebral Hemorrhage.

Authors:  Naaem Simaan; Jeremy Molad; Shlomi Peretz; Andrei Filioglo; Eitan Auriel; Hen Hallevi; Estelle Seyman; Rani Barnea; José E Cohen; Ronen R Leker; Asaf Honig
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

9.  Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery.

Authors:  Quan-Ting Chen; Yi Liu; Yeu-Chin Chen; Chung-Hsing Chou; Yu-Pang Lin; Yun-Qian Lin; Ming-Chen Tsai; Bo-Kang Chang; Tsung-Han Ho; Chun-Chi Lu; Yueh-Feng Sung
Journal:  Front Neurol       Date:  2022-10-04       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.